Towards targeted therapy of chronic lymphocytic leukaemia - European Medical Journal

Continue

Towards targeted therapy of chronic lymphocytic leukaemia

Oncology
Jacqueline Barrientos, MD, of North Shore-LIJ Cancer Institute, Lake Success, NY, summarises recent progress in the treatment of chronic lymphocytic leukaemia at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

We’ve noticed you’re accessing
from North/South America.